The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Silencing of microRNAs in vivo with ‘antagomirs’
Abstract
MicroRNAs (miRNAs) are an abundant class of non-coding RNAs that are believed to be important in many biological processes through regulation of gene expression. The precise molecular function of miRNAs in mammals is largely unknown and a better understanding will require loss-of-function studies in vivo. Here we show that a novel class of chemically engineered oligonucleotides, termed 'antagomirs', are efficient and specific silencers of endogenous miRNAs in mice. Intravenous administration of antagomirs against miR-16, miR-122, miR-192 and miR-194 resulted in a marked reduction of corresponding miRNA levels in liver, lung, kidney, heart, intestine, fat, skin, bone marrow, muscle, ovaries and adrenals. The silencing of endogenous miRNAs by this novel method is specific, efficient and long-lasting. The biological significance of silencing miRNAs with the use of antagomirs was studied for miR-122, an abundant liver-specific miRNA. Gene expression and bioinformatic analysis of messenger RNA from antagomir-treated animals revealed that the 3' untranslated regions of upregulated genes are strongly enriched in miR-122 recognition motifs, whereas downregulated genes are depleted in these motifs. Analysis of the functional annotation of downregulated genes specifically predicted that cholesterol biosynthesis genes would be affected by miR-122, and plasma cholesterol measurements showed reduced levels in antagomir-122-treated mice. Our findings show that antagomirs are powerful tools to silence specific miRNAs in vivo and may represent a therapeutic strategy for silencing miRNAs in disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Methods have been developed to manipulate miRNA function pharmacologically, facilitating the development of new cancer therapeutic strategies (Hutvagner et al., 2004; Krutzfeldt et al., 2005).”
From Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21 (2010) · cites this paper as Krutzfeldt et al., 2005
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Self-citationPruitt, K. D., Tatusova, T. A., & Maglott, D. R. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl842 · Cited by 4,441
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
Self-citationA microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,642
Cited by
Sorted by citations
Items 901–1,000 of 1,017
miRNAs associated with prostate cancer risk and progression
Luu, H. N., Lin, H., Sørensen, K. D., Ogunwobi, O. O., Kumar, N. B., Chornokur, G., Phelan, C., Jones, D., Kidd, L. R., Batra, J., et al. (2017) · BMC Urology · doi:10.1186/s12894-017-0206-6 · Cited by 112
Molecular Mechanisms of Muscle Plasticity with Exercise
Hoppeler, H. H., Baum, O., Lurman, G. J., & Mueller, M. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100042 · Cited by 131
Signatures of RNA binding proteins globally coupled to effective microRNA target sitesPreprint
Skanderup, A. J., Wen, J., Marks, D. S., & Krogh, A. (2010) · Genome Research · doi:10.1101/gr.103259.109 · Cited by 112
Controlling SIRT1 expression by microRNAs in health and metabolic disease
Lee, J., & Kemper, J. K. (2010) · Aging · doi:10.18632/aging.100184 · Cited by 112
Yu, Z., Jian, Z., Shen, S., Purisima, E. O., & Wang, E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1032 · Cited by 109
MicroRNA 10a Marks Regulatory T Cells
Jeker, L. T., Zhou, X., Gershberg, K., de Kouchkovsky, D. A., Morar, M. M., Stadthagen, G., Lund, A. H., & Bluestone, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036684 · Cited by 116
Nagata, Y., Nakasa, T., Mochizuki, Y., Ishikawa, M., Miyaki, S., Shibuya, H., Yamasaki, K., Adachi, N., Asahara, H., & Ochi, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24762 · Cited by 110
miRNAs: Effectors of Environmental Influences on Gene Expression and Disease
Hudder, A., & NOVAK, R. F. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn033 · Cited by 115
Breast cancer and microRNAs: therapeutic impact
Iorio, M. V., Casalini, P., Piovan, C., Braccioli, L., & Tagliabue, E. (2011) · The Breast · doi:10.1016/s0960-9776(11)70297-1 · Cited by 111
Tzur, G., Levy, A., Meiri, E., Barad, O., Spector, Y., Bentwich, Z., Mizrahi, L., Katzenellenbogen, M., Ben-Shushan, E., Reubinoff, B. E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003726 · Cited by 113
An Introduction to Small Non-coding RNAs: miRNA and snoRNA
Holley, C. L., & Topkara, V. K. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6290-z · Cited by 114
An intronic microRNA silences genes that are functionally antagonistic to its host gene
Barik, S. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn513 · Cited by 110
Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140
Nicolás, F. E., Pais, H., Schwach, F., Lindow, M., Kauppinen, S., Moulton, V., & Dalmay, T. (2008) · RNA · doi:10.1261/rna.1221108 · Cited by 110
The clinical potential of microRNAs
Budhu, A., Ji, J., & Wang, X. W. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-37 · Cited by 111
Chai, C., Rivkin, M., Berkovits, L., Simerzin, A., Zorde‐Khvalevsky, E., Rosenberg, N., Klein, S., Yaish, D., Durst, R. Y., Shpitzen, S., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.013 · Cited by 109
microRNA expression in the eyes and their significance in relation to functions
Xu, S. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.11.003 · Cited by 110
MicroRNA-mediated control in the skin
Yi, R., & Fuchs, E. V. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.92 · Cited by 115
Innate Immunity and Alcoholic Liver Disease
Szabó, G., Petrášek, J., & Bala, S. (2012) · Digestive Diseases · doi:10.1159/000341126 · Cited by 111
Emerging functions of microRNAs in glioblastoma
Lawler, S. E., & Chiocca, E. A. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9843-2 · Cited by 108
MicroRNA in central nervous system trauma and degenerative disorders
Liu, N., & Xu, X. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00168.2010 · Cited by 114
microRNA Therapeutics in Cardiovascular Disease Models
Dangwal, S., & Thum, T. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135957 · Cited by 112
Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis
Novák, J., Olejníčková, V., Tkáčová, N., & Santulli, G. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-22380-3_5 · Cited by 95
The Network of Non-coding RNAs in Cancer Drug Resistance
Corrà, F., Agnoletto, C., Minotti, L., Baldassari, F., & Volinia, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00327 · Cited by 109
Su, J., Wu, F., Xia, H., Wu, Y., & Liu, S. (2019) · Chemical Science · doi:10.1039/c9sc04823e · Cited by 109
Biological Activity and Biotechnological Aspects of Locked Nucleic Acids
Lundin, K. E., Højland, T., Hansen, B. R., Persson, R., Bramsen, J. B., Kjems, J., Koch, T., Wengel, J., & Smith, C. I. E. (2013) · Advances in genetics · doi:10.1016/b978-0-12-407676-1.00002-0 · Cited by 114
Noncanonical TGF-β Signaling During Mammary Tumorigenesis
Parvani, J. G., Taylor, M. A., & Schiemann, W. P. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9207-3 · Cited by 112
Everything you wanted to know about small RNA but were afraid to ask
Boyd, S. D. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.32 · Cited by 108
Liu, X., Song, W., Sun, T., Zhang, P., & Wang, J. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100315q · Cited by 109
Efficient in vivo microRNA targeting of liver metastasis
Huynh, C., Segura, M. F., Gaziel‐Sovran, A., Menéndez, S., Darvishian, F., Chiriboga, L. A., Levin, B., Meruelo, D., Osman, I., Zavadil, J., et al. (2010) · Oncogene · doi:10.1038/onc.2010.523 · Cited by 109
Epigenetic-related therapeutic challenges in cardiovascular disease
Schiano, C., Vietri, M. T., Grimaldi, V., Picascia, A., Pascale, M. R. D., & Claudio Napoli, A. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.005 · Cited by 111
Bassendine, M. F., Sheridan, D. A., Bridge, S. H., Felmlee, D. J., & Neely, R. D. G. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0356-2 · Cited by 110
Boettger, T., & Braun, T. W. (2012) · Circulation Research · doi:10.1161/circresaha.111.247742 · Cited by 111
Non-coding RNAs: a key to future personalized molecular therapy?
Galasso, M., Sana, M. E., & Volinia, S. (2010) · Genome Medicine · doi:10.1186/gm133 · Cited by 108
Chan, X. H. D., Nama, S., Gopal, F., Rizk, P., Ramasamy, S., Sundaram, G., Ow, G. S., Vladimirovna, I. A., Tanavde, V., Haybaeck, J., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.07.012 · Cited by 84
The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
Cardoso, G. S. H. R., Corrêa, L. H., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.563816 · Cited by 113
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer
Rachagani, S., Macha, M. A., Heimann, N., Seshacharyulu, P., Haridas, D., Chugh, S., & Batra, S. K. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.020 · Cited by 107
Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease
Tian, Y., Wong, V. W., Chan, H. L., & Cheng, A. S. L. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.010 · Cited by 108
Drebber, U. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1036 · Cited by 111
RNAi-based therapeutic strategies for metabolic disease
Czech, M., Aouadi, M., & Tesz, G. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.57 · Cited by 108
Functional genetics for all: engineered nucleases, CRISPR and the gene editing revolution
Gilles, A. F., & Averof, M. (2014) · EvoDevo · doi:10.1186/2041-9139-5-43 · Cited by 110
Bijkerk, R., de Bruin, R. G., Solingen, C. V., van Gils, J. M., Duijs, J. M. G. J., van der Veer, E. P., Rabelink, T. J., Humphreys, B. D., & van Zonneveld, A. J. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.029 · Cited by 109
Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond
Daiber, A., Hahad, O., Andreadou, I., Steven, S., Daub, S., & Münzel, T. F. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101875 · Cited by 110
MicroRNA in Cutaneous Wound Healing: A New Paradigm
Shilo, S., Roy, S., Khanna, S., & Sen, C. K. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0568 · Cited by 107
Vogel, P., Schneider, M. F., Wettengel, J., & Stafforst, T. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402634 · Cited by 108
MicroRNAs as novel players in skin development, homeostasis and disease
Schneider, M. R. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10568.x · Cited by 111
MicroRNA 302a Is a Novel Modulator of Cholesterol Homeostasis and Atherosclerosis
Meiler, S. U., Baumer, Y., Toulmin, E., Seng, K., & Boisvert, W. A. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304878 · Cited by 111
MicroRNA 486 is a potentially novel target for the treatment of spinal cord injury
Jee, M. K., Jung, J. S., Choi, J. I., Jang, J. A., Kang, K. S., Im, Y. B., & Kang, S. K. (2012) · Brain · doi:10.1093/brain/aws047 · Cited by 91
Ásgeirsdóttir, S. A., Solingen, C. V., Kurniati, N. F., Zwiers, P. J., Heeringa, P., van Meurs, M., Satchell, S. C., Saleem, M. A., Mathieson, P. W., Banas, B., et al. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00400.2011 · Cited by 107
Lee, C. H., Lee, S.-H., Kim, J. H., Noh, Y.-H., Noh, G., & Lee, S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.30 · Cited by 106
MicroRNA based theranostics for brain cancer: basic principles
Petrescu, G. E. D., Sabo, A. A., Torsin, L. I., Călin, G. A., & Dragomir, M. P. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1180-5 · Cited by 110
siRNA- and miRNA-based therapeutics for liver fibrosis
Zhao, Z., Lin, C., & Cheng, K. (2019) · Translational research · doi:10.1016/j.trsl.2019.07.007 · Cited by 106
Mirnas and Their Potential For Use Against Cancer and Other Diseases
Tili, E., Michaille, J., Gandhi, V. V., Plunkett, W. K., Sampath, D., & Calin, G. A. (2007) · Future Oncology · doi:10.2217/14796694.3.5.521 · Cited by 105
MicroRNA-203 contributes to skin re-epithelialization
Viticchiè, G., Lena, A. M., Cianfarani, F., Odorisio, T., Annicchiarico-Petruzzelli, M., Melino, G., & Candi, E. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.174 · Cited by 105
MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1
Yang, Y., Yang, L., Liang, X., & Zhu, G. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430303 · Cited by 105
Joint analysis of miRNA and mRNA expression data
Muniategui, A., Pey, J., Planes, F. J., & Rubio, Á. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs028 · Cited by 106
Jansen, J., Jansen, K., Neven, E., Poesen, R., Othman, A., van Mil, A., Sluijter, J. P. G., Toraño, J. S., Zaal, E. A., Berkers, C. R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821809116 · Cited by 106
Hepatic function is preserved in the absence of mature microRNAs #
Hand, N. J., Master, Z. R., Lay, J. E. L., & Friedman, J. R. (2008) · Hepatology · doi:10.1002/hep.22656 · Cited by 105
MicroRNAs as therapeutic targets in human cancers
Shah, M., & Călin, G. A. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1229 · Cited by 108
Responses of microRNAs 124a and 223 following spinal cord injury in mice
Nakanishi, K., Nakasa, T., Tanaka, N., Ishikawa, M., Yamada, K., Yamasaki, K., Kamei, N., Izumi, B., Adachi, N., Miyaki, S., et al. (2009) · Spinal Cord · doi:10.1038/sc.2009.89 · Cited by 104
Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation
Shibuya, H., Nakasa, T., Adachi, N., Nagata, Y., Ishikawa, M., Deie, M., Suzuki, O., & Ochi, M. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0710-1 · Cited by 127
The role of microRNAs in cancers of the upper gastrointestinal tract
Song, S., & Ajani, J. A. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.210 · Cited by 104
Kerr, T. A., Korenblat, K., & Davidson, N. O. (2011) · Translational research · doi:10.1016/j.trsl.2011.01.008 · Cited by 106
Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes
Calin, G. A., & Croce, C. M. (2009) · Blood · doi:10.1182/blood-2009-07-192740 · Cited by 104
McClure, C., Brudecki, L. E., Ferguson, D. A., Yao, Z. Q., Moorman, J. P., McCall, C. E., & Gazzar, M. E. (2014) · Infection and Immunity · doi:10.1128/iai.01495-14 · Cited by 104
MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer
Ye, G., Huang, K., Yu, J., Zhao, L., Zhu, X., Yang, Q., Li, W., Jiang, Y., Zhuang, B., Liu, H., et al. (2017) · Theranostics · doi:10.7150/thno.20512 · Cited by 104
Optochemische Steuerung biologischer Vorgänge in Zellen und Tieren
Ankenbruck, N., Courtney, T. M., Naro, Y., & Deiters, A. (2017) · Angewandte Chemie · doi:10.1002/ange.201700171 · Cited by 106
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact
Caturano, A., Acierno, C., Nevola, R., Pafundi, P. C., Galiero, R., Rinaldi, L., Salvatore, T., Adinolfi, L. E., & Sasso, F. C. (2021) · Processes · doi:10.3390/pr9010135 · Cited by 109
MicroRNAs as new therapeutic targets and tools in cancer
Gandellini, P., Profumo, V., Folini, M., & Zaffaroni, N. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.550878 · Cited by 103
The Non-coding 3′UTR of CD44 Induces Metastasis by Regulating Extracellular Matrix Functions
Jeyapalan, Z., & Yang, B. B. (2012) · Journal of Cell Science · doi:10.1242/jcs.100818 · Cited by 103
MicroRNA Detection and Target Prediction: Integration of Computational and Experimental Approaches
Chaudhuri, K., & Chatterjee, R. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0549 · Cited by 103
Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C
Morita, K., Taketomi, A., Shirabe, K., Umeda, K., Kayashima, H., Ninomiya, M., Uchiyama, H., Soejima, Y., & Maehara, Y. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02433.x · Cited by 102
Double-stranded regions are essential design components of potent inhibitors of RISC function
Vermeulen, A., Robertson, B., Dalby, A. B., Marshall, W. S., Karpilow, J. M., Leake, D., Khvorova, A., & Baskerville, S. (2007) · RNA · doi:10.1261/rna.448107 · Cited by 102
Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy
Iranifar, E., Seresht, B. M., Momeni, F., Fadaei, E., Mehr, M. H., Ebrahimi, Z., Rahmati, M., Kharazinejad, E., & Mirzaei, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27214 · Cited by 93
Saleh, R., Toor, S. M., Nair, V. S., & Elkord, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01469 · Cited by 107
Ge, Q., Brichard, S. M., Yi, X., & Li, Q. (2014) · Journal of Immunology Research · doi:10.1155/2014/987285 · Cited by 105
Torres, A. G., Fabani, M. M., Vigorito, E., & Gait, M. J. (2011) · RNA · doi:10.1261/rna.2533811 · Cited by 103
Liu, N., Cui, R., Sun, Y. H., Guo, R., Mao, Y., Tang, L., Jiang, W., Liu, X., Cheng, Y., He, Q., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28468 · Cited by 101
Inferring MicroRNA Activities by Combining Gene Expression with MicroRNA Target Prediction
Cheng, C., & Li, L. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001989 · Cited by 100
miRNA cassettes in viral vectors: Problems and solutions
Liu, Y. P., & Berkhout, B. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.05.014 · Cited by 101
MicroRNAs as biomarkers and therapeutic drugs in human cancer
Osaki, M., Takeshita, F., & Ochiya, T. (2008) · Biomarkers · doi:10.1080/13547500802646572 · Cited by 102
Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects
Bolmeson, C., Esguerra, J. L. S., Salehi, A. A., Speidel, D., Eliasson, L., & Cilio, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.024 · Cited by 102
Asslaber, D., Hofbauer, J. P., Seyfried, I., Desch, P., Stöcher, M., Tinhofer, I., Egle, A., Merkel, O., & Greil, R. (2010) · Blood · doi:10.1182/blood-2009-07-234823 · Cited by 103
Gambari, R., Fabbri, E., Borgatti, M., Lampronti, I., Finotti, A., Brognara, E., Bianchi, N., Manicardi, A., Marchelli, R., & Corradini, R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.007 · Cited by 103
microRNAs in the onset and development of cardiovascular disease
Vickers, K. C., Rye, K., & Tabet, F. (2013) · Clinical Science · doi:10.1042/cs20130203 · Cited by 102
Cheng, C., Fu, X., Alves, P., & Gerstein, M. (2009) · Genome biology · doi:10.1186/gb-2009-10-9-r90 · Cited by 103
Small molecules targeting microRNA for cancer therapy: Promises and obstacles
Wen, D., Danquah, M. K., Chaudhary, A., & Mahato, R. I. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.011 · Cited by 104
MicroRNAs: New actors in the oral cancer scene
Wu, B.-H., Xiong, X., Jia, J., & Zhang, W. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.03.019 · Cited by 101
Fulci, V., Colombo, T., Chiaretti, S., Messina, M., Citarella, F., Tavolaro, S., Guarini, A. R., Foà, R., & Macino, G. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20709 · Cited by 101
Gottwein, J. M., & Bukh, J. (2008) · Advances in virus research · doi:10.1016/s0065-3527(08)00002-x · Cited by 101
Du, L., Subauste, M. C., DeSevo, C. G., Zhao, Z., Baker, M., Borkowski, R. J., Schageman, J. J., Greer, R. M., Yang, C., Suraokar, M. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039167 · Cited by 100
Hazarika, S., Farber, C. R., Dokun, A. O., Pitsillides, A. N., Wang, T., Lye, R. J., & Annex, B. H. (2013) · Circulation · doi:10.1161/circulationaha.112.000860 · Cited by 100
Regulation of cancer metastasis by cell-free miRNAs
Alečković, M., & Kang, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.005 · Cited by 101
MicroRNAs in Cardiovascular Biology and Heart Disease
Catalucci, D., Gallo, P., & Condorelli, G. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.857425 · Cited by 100
Virus Meets Host MicroRNA: the Destroyer, the Booster, the Hijacker
Guo, Y. E., & STEITZ, J. A. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00871-14 · Cited by 97
A statin‐regulated microRNA represses human c‐Myc expression and function
Takwi, A. A., Li, Y., Buscaglia, L. E. B., Zhang, J., Choudhury, S. N., Park, A. K., Liu, M., Young, K. H., Park, W., Martin, R. C. G., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101045 · Cited by 101
Let-7 microRNA as a potential therapeutic target with implications for immunotherapy
Gilles, M.-E., & Slack, F. J. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1535594 · Cited by 99
Tang, T., Hu, Y., Peng, M., Chu, W., Hu, Y., & Zhong, L. (2019) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2019.04.006 · Cited by 100
Polymeric Carriers for Nucleic Acid Delivery: Current Designs and Future Directions
Peng, L., & Wagner, E. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00999 · Cited by 102
Sharma, S., Liu, J., Wei, J., Yuan, H., Zhang, T., & Bishopric, N. H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200234 · Cited by 98
Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
Cheng, H. S., Njock, M.-S., Khyzha, N., Dang, L. T., & Fish, J. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00422 · Cited by 69
Metadata
- Authors
- Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M.
- Affiliations
- Rockefeller University (US)
- New York University (US)
- Alnylam Pharmaceuticals (United States) (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Stoffel, Markus
- ORCID
- Venue
- Nature
- Published
- 2005-10-30
- Volume
- 438
- Issue
- 7068
- Pages
- 685-689
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2161693225
- Cited by
- 3,949
- References
- 27
- Citations by year
- 2026: 51 · 2025: 75 · 2024: 98 · 2023: 109 · 2022: 138 · 2021: 148 · 2020: 155 · 2019: 135 · 2018: 169 · 2017: 169 · 2016: 210 · 2015: 249 · 2014: 326 · 2013: 329 · 2012: 318
- FWCI
- 52.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
- Keywords
- microRNA, antagomir, microRNA silencing, in vivo gene regulation, miR-122, miR-16, miR-192, miR-194, miR-196, Hoxb8, Sonic hedgehog, embryonic development, non-coding RNA, oligonucleotide therapeutics
- MeSH terms
- Antagomirs, Animals, Cholesterol, Oligonucleotides, Sensitivity and Specificity, Substrate Specificity, Time Factors, Down-Regulation, Up-Regulation, RNA, Complementary, Computational Biology, 3' Untranslated Regions, Gene Silencing, MicroRNAs, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review